The emergence of Lyme disease.
暂无分享,去创建一个
[1] H. Karch,et al. Intracellular persistence ofBorrelia burgdorferi in human synovial cells , 2005, Rheumatology International.
[2] T. Schwan,et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[3] Johanna W Lampe,et al. Antibiotic use in relation to the risk of breast cancer , 2004, JAMA.
[4] A. Steere,et al. Elucidation of Lyme arthritis , 2004, Nature Reviews Immunology.
[5] Heiko Becker,et al. Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins* , 2004, Journal of Biological Chemistry.
[6] E. Fikrig,et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. , 2004, The Journal of clinical investigation.
[7] Thomas R. Riley,et al. A Randomized Double-blind Placebo-controlled Trial , 2004 .
[8] A. Steere,et al. Inflammatory Cytokine Production Predominates in Early Lyme Disease in Patients with Erythema Migrans , 2003, Infection and Immunity.
[9] M. Hanson,et al. Progress and controversy surrounding vaccines against Lyme disease , 2003, Expert review of vaccines.
[10] P. Krause,et al. Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans 12 , 2003, The Journal of Immunology.
[11] A. Steere,et al. Asymptomatic infection with Borrelia burgdorferi. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] V. Blaho,et al. Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR21 , 2003, The Journal of Immunology.
[13] E. Hayes,et al. How can we prevent Lyme disease? , 2003, The New England journal of medicine.
[14] A. Steere,et al. The presenting manifestations of Lyme disease and the outcomes of treatment. , 2003, The New England journal of medicine.
[15] Q. Fang,et al. MOLECULAR PHYLOGENETIC ANALYSES INDICATE THAT THE IXODES RICINUS COMPLEX IS A PARAPHYLETIC GROUP , 2003, The Journal of parasitology.
[16] R. Dornbush,et al. Duration of Antibiotic Therapy for Early Lyme Disease , 2003, Annals of Internal Medicine.
[17] S. Norris,et al. A plasmid‐encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host , 2003, Molecular microbiology.
[18] A. Steere,et al. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. , 2003, The Journal of infectious diseases.
[19] A. Steere,et al. Serodiagnosis of Lyme Disease by Kinetic Enzyme-Linked Immunosorbent Assay Using Recombinant VlsE1 or Peptide Antigens of Borrelia burgdorferi Compared with 2-Tiered Testing Using Whole-Cell Lysates , 2003, The Journal of infectious diseases.
[20] A. Steere,et al. Prospective study of coinfection in patients with erythema migrans. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] A. Steere,et al. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. , 2003, Arthritis and rheumatism.
[22] Felicia Keesing,et al. The ecology of infectious disease: Effects of host diversity and community composition on Lyme disease risk , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Steere,et al. Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. , 2003, The American journal of medicine.
[24] R. Kennedy,et al. OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients , 2002, Journal of Clinical Microbiology.
[25] G. Stanek,et al. Lyme Borreliosis: Biology, Epidemiology and Control , 2002 .
[26] A. Steere. A 58-year-old man with a diagnosis of chronic lyme disease. , 2002, JAMA.
[27] A. Hassett,et al. Contributions of societal and geographical environments to "chronic Lyme disease": the psychopathogenesis and aporology of a new "medically unexplained symptoms" syndrome. , 2002, Environmental health perspectives.
[28] E. Fikrig,et al. Molecular Adaptation of Borrelia burgdorferi in the Murine Host , 2002, The Journal of experimental medicine.
[29] S. Wikel,et al. Changes in Temporal and Spatial Patterns of Outer Surface Lipoprotein Expression Generate Population Heterogeneity and Antigenic Diversity in the Lyme Disease Spirochete, Borrelia burgdorferi , 2002, Infection and Immunity.
[30] H. Kampen,et al. Seroprevalence of Babesia Infections in Humans Exposed to Ticks in Midwestern Germany , 2002, Journal of Clinical Microbiology.
[31] Ruth R. Montgomery,et al. Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. , 2002, The Journal of infectious diseases.
[32] S. Telford,et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] A. Steere,et al. Clinical Characteristics and Treatment Outcome of Early Lyme Disease in Patients with Microbiologically Confirmed Erythema Migrans , 2002, Annals of Internal Medicine.
[34] Uriel Kitron,et al. Predicting the Risk of Lyme Disease: Habitat Suitability for Ixodes scapularis in the North Central United States , 2002, Emerging infectious diseases.
[35] F. Liang,et al. An Immune Evasion Mechanism for Spirochetal Persistence in Lyme Borreliosis , 2002, The Journal of experimental medicine.
[36] S. Etti,et al. Host association of Borrelia burgdorferi sensu lato--the key role of host complement. , 2002, Trends in microbiology.
[37] N. J. Zulqarni,et al. Overdiagnosis and overtreatment of Lyme disease in children , 2002, The Pediatric infectious disease journal.
[38] L. Bennet,et al. Reinfection with Lyme Borreliosis: A Retrospective Follow-up Study in Southern Sweden , 2002, Scandinavian journal of infectious diseases.
[39] R. Massung,et al. Human Granulocytic Ehrlichiosis as a Common Cause of Tick-associated Fever in Southeast Sweden: Report from a Prospective Clinical Study , 2002, Scandinavian journal of infectious diseases.
[40] E. Korenberg,et al. Ecology of Borrelia burgdorferi sensu lato in Russia. , 2002 .
[41] A. Steere,et al. Cellular and Humoral Immune Responses toBorrelia burgdorferi Antigens in Patients with Culture-Positive Early Lyme Disease , 2001, Infection and Immunity.
[42] B K Szymanski,et al. Lyme disease in New York State: spatial pattern at a regional scale. , 2001, The American journal of tropical medicine and hygiene.
[43] R Ruthazer,et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] C H Schmid,et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. , 2001, The New England journal of medicine.
[45] R. Marcus,et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. , 2001, The New England journal of medicine.
[46] M. Hotopf,et al. Medically unexplained symptoms: an epidemiological study in seven specialities. , 2001, Journal of psychosomatic research.
[47] E. Dobrikova,et al. Genetic manipulation of spirochetes--light at the end of the tunnel. , 2001, Trends in microbiology.
[48] A. Steere,et al. Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1αL Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells1 , 2001, The Journal of Immunology.
[49] Jeffrey Talkington,et al. Role of Fc Gamma Receptors in Triggering Host Cell Activation and Cytokine Release by Borrelia burgdorferi , 2001, Infection and Immunity.
[50] Maria Labandeira-Rey,et al. Decreased Infectivity in Borrelia burgdorferi Strain B31 Is Associated with Loss of Linear Plasmid 25 or 28-1 , 2001, Infection and Immunity.
[51] H. Kerl,et al. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. , 2000, The Journal of investigative dermatology.
[52] R. Lane,et al. A COMPARATIVE STUDY OF MAMMALIAN AND REPTILIAN ALTERNATIVE PATHWAY OF COMPLEMENT-MEDIATED KILLING OF THE LYME DISEASE SPIROCHETE (BORRELIA BURGDORFERI) , 2000, The Journal of parasitology.
[53] W. Edwards,et al. Death from inappropriate therapy for Lyme disease. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[54] T. Burkot,et al. Borrelia Isolates in Northern Colorado Identified as Borrelia bissettii , 2000, Journal of Clinical Microbiology.
[55] A. Steere,et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] J. Posey,et al. Lack of a role for iron in the Lyme disease pathogen. , 2000, Science.
[57] J. Leong,et al. Identification of a candidate glycosaminoglycan‐binding adhesin of the Lyme disease spirochete Borrelia burgdorferi , 2000, Molecular microbiology.
[58] O. White,et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi , 2000, Molecular microbiology.
[59] T. Schwan,et al. Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice , 2000, Journal of Clinical Microbiology.
[60] Ennis,et al. Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant , 2000 .
[61] S. Barthold,et al. Immunity and Resolution of Lyme Disease Are Critical for Protective burgdorferi Borrelia T-Cell-Independent Responses to , 2000 .
[62] S. Bodary,et al. Characterization of a candidate Borrelia burgdorferiβ3‐chain integrin ligand identified using a phage display library , 1999, Molecular microbiology.
[63] A. Steere,et al. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. , 1999, Arthritis and rheumatism.
[64] R. M. Wooten,et al. Dual Role of Interleukin-10 in Murine Lyme Disease: Regulation of Arthritis Severity and Host Defense , 1999, Infection and Immunity.
[65] A. Steere,et al. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. , 1999, Arthritis and rheumatism.
[66] D. Dykhuizen,et al. Four Clones of Borrelia burgdorferiSensu Stricto Cause Invasive Infection in Humans , 1999, Infection and Immunity.
[67] R. Nadelman,et al. Comparison of Culture-Confirmed Erythema Migrans Caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia , 1999, Annals of Internal Medicine.
[68] A. Steere,et al. The Immunoglobulin (IgG) Antibody Response to OspA and OspB Correlates with Severe and Prolonged Lyme Arthritis and the IgG Response to P35 Correlates with Mild and Brief Arthritis , 1999, Infection and Immunity.
[69] Barbara J. B. Johnson,et al. Identification of a 47 kDa fibronectin‐binding protein expressed by Borrelia burgdorferi isolate B31 , 1998, Molecular microbiology.
[70] E. Fikrig,et al. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. , 1998, The Journal of infectious diseases.
[71] B. P. Guo,et al. Decorin‐binding adhesins from Borrelia burgdorferi , 1998, Molecular microbiology.
[72] E. Hilton,et al. Psychological factors in the prediction of Lyme disease course. , 1998, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[73] R. Schell,et al. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. , 1998, The Journal of infectious diseases.
[74] S. Norris,et al. Genetic Variation of the Borrelia burgdorferi Gene vlsE Involves Cassette-Specific, Segmental Gene Conversion , 1998, Infection and Immunity.
[75] A. Steere,et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.
[76] C. Schmid,et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. , 1998, The New England journal of medicine.
[77] B. P. Guo,et al. Active and Passive Immunity against Borrelia burgdorferi Decorin Binding Protein A (DbpA) Protects against Infection , 1998, Infection and Immunity.
[78] P. Oschmann,et al. Stages and syndromes of neuroborreliosis , 1998, Journal of Neurology.
[79] R. Horwitz,et al. The Consequences of Overdiagnosis and Overtreatment of Lyme Disease: An Observational Study , 1998, Annals of Internal Medicine.
[80] J. Coburn,et al. Different Classes of Proteoglycans Contribute to the Attachment of Borrelia burgdorferi to Cultured Endothelial and Brain Cells , 1998, Infection and Immunity.
[81] S. Salzberg,et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi , 1997, Nature.
[82] T. Bugge,et al. Plasminogen Is Required for Efficient Dissemination of B. burgdorferi in Ticks and for Enhancement of Spirochetemia in Mice , 1997, Cell.
[83] E. Fikrig,et al. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. , 1997, Immunity.
[84] R. Würzner,et al. Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi , 1997, Medical Microbiology and Immunology.
[85] R. Pollack,et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. , 1996, JAMA.
[86] S. Norris,et al. Modulation of immunity to Borrelia burgdorferi by ultraviolet irradiation: Differential effect on Th1 and Th2 immune responses , 1995, European journal of immunology.
[87] A. Keane-Myers,et al. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. , 1995, Journal of immunology.
[88] D. Dennis,et al. Biliary complications in the treatment of unsubstantiated Lyme disease. , 1995, The Journal of infectious diseases.
[89] A. Spielman. The Emergence of Lyme Disease and Human Babesiosis in a Changing Environment a , 1994, Annals of the New York Academy of Sciences.
[90] C. Schmid,et al. Treatment of Lyme arthritis. , 1994, Arthritis and rheumatism.
[91] U. Schaible,et al. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. , 1994, Immunology letters.
[92] A. Steere,et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. , 1994, The New England journal of medicine.
[93] A. Steere,et al. The overdiagnosis of Lyme disease. , 1993, JAMA.
[94] A. Steere,et al. Western blotting in the serodiagnosis of Lyme disease. , 1993, The Journal of infectious diseases.
[95] N. Pavlović,et al. [Epidemiology of Lyme borreliosis]. , 1993, Glas. Srpska akademija nauka i umetnosti. Odeljenje medicinskih nauka.
[96] Jean Côté,et al. Lyme Disease , 1991, International journal of dermatology.
[97] U. Wurster,et al. Chronic neurologic manifestations of Lyme disease. , 1991, The New England journal of medicine.
[98] P. Duray. Clinical pathologic correlations of Lyme disease. , 1989, Reviews of infectious diseases.
[99] A. Steere. Medical progress. Lyme disease , 1989 .
[100] P. Duray,et al. Clinical Pathologic Correlations of Lyme Disease by Stage , 1988, Annals of the New York Academy of Sciences.
[101] A. Steere,et al. The clinical evolution of Lyme arthritis. , 1987, Annals of internal medicine.
[102] A. Steere,et al. The early clinical manifestations of Lyme disease. , 1983, Annals of internal medicine.
[103] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.